Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Acta Pharmacologica Sinica
Xin ZhangQi-Zhu Tang

Abstract

Cardiovascular and metabolic diseases are the leading causes of death and disability worldwide and impose a tremendous socioeconomic burden on individuals as well as the healthcare system. Fibronectin type III domain-containing 5 (FNDC5) is a widely distributed transmembrane glycoprotein that can be proteolytically cleaved and secreted as irisin to regulate glycolipid metabolism and cardiovascular homeostasis. In this review, we present the current knowledge on the predictive and therapeutic role of FNDC5 in a variety of cardiovascular and metabolic diseases, such as hypertension, atherosclerosis, ischemic heart disease, arrhythmia, metabolic cardiomyopathy, cardiac remodeling, heart failure, diabetes mellitus, and obesity.

References

Sep 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M E Rosenfeld, R Ross
Jul 12, 2002·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Andreu Ferrer-MartínezKenneth R Chien
Oct 18, 2002·Gene·Andreas TeufelHeiner Westphal
Dec 24, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Joerg HeerenThomas Grewal
Aug 19, 2007·Circulation·M W Merx, C Weber
Feb 2, 2013·Diabetes Research and Clinical Practice·Yeon-Kyung ChoiKeun-Gyu Park
Feb 26, 2013·The Journal of Clinical Endocrinology and Metabolism·José María Moreno-NavarreteJosé Manuel Fernández-Real
Apr 18, 2013·PloS One·Arturo Roca-RivadaMaría Pardo
May 15, 2013·Journal of Hepatology·Hui-Jie ZhangXiao-Ying Li
Aug 1, 2013·Physiological Reviews·Paul N Hopkins
Jan 1, 2014·American Journal of Human Biology : the Official Journal of the Human Biology Council·Ana B CrujeirasFelipe F Casanueva
Jan 23, 2014·Diabetes Research and Clinical Practice·Mehmet Aytac YukselRiza Madazli
Feb 28, 2014·Adipocyte·Fabian Sanchis-Gomar, Carme Perez-Quilis
Mar 1, 2014·Peptides·Tuncay KulogluSuleyman Aydin
Mar 13, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J Y HuhC S Mantzoros
Mar 19, 2014·The Journal of Clinical Endocrinology and Metabolism·María F GarcésJorge E Caminos
May 13, 2014·The American Journal of Medicine·Enzo EmanueleAlejandro Lucia
May 23, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Mariusz KuzmickiJacek Szamatowicz
Jun 12, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·K N AronisC S Mantzoros
Jul 17, 2014·The Journal of Clinical Endocrinology and Metabolism·Chia Lin ChangI Ting Liang
Jul 26, 2014·Metabolism: Clinical and Experimental·Grigorios PanagiotouChristos S Mantzoros
Aug 13, 2014·European Journal of Clinical Investigation·Carolina Gutierrez-RepisoEduardo Garcia-Fuentes
Sep 7, 2014·Clinical Biochemistry·Rafael AlisMilagros Rocha
Dec 2, 2014·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·S AydinS Bico

❮ Previous
Next ❯

Citations

Apr 2, 2021·International Journal of Endocrinology·Hui LiDongqi Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.